|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|
| ASSETS | |
| CURRENT ASSETS: | |
| Cash and cash equivalents | |
| Accounts receivable, net of credit losses of zero as of December 31, 2023 and 2022, respectively | |
| Other current assets | |
| Inventory | |
| TOTAL CURRENT ASSETS | |
| NON-CURRENT ASSETS: | |
| Property and equipment, net | |
| Restricted cash | |
| Other assets | |
| TOTAL NON-CURRENT ASSETS | |
| TOTAL ASSETS | |
| LIABILITIES AND REDEEMABLE CROSSOVER PREFERRED SHARES, NET OF CAPITAL DEFICIENCY | |
| CURRENT LIABILITIES: | |
| Accounts payable and accruals: | |
| Trade | |
| Other | |
| SAFE liability | |
| Convertible loans | |
| Current maturities of bridge loans | |
| TOTAL CURRENT LIABILITIES | |
| NON-CURRENT LIABILITIES | |
| Bridge loans | |
| Redeemable crossover preferred shares - put option derivative | |
| TOTAL LIABILITIES | |
| Redeemable crossover preferred shares and incentive shares, par value NIS 0.01 per share; 2,800,000 and zero0 shares authorized as of December 31, 2023 and 2022; 1,850,147 and zero0 shares issued and outstanding at December 31, 2023 and 2022, respectively | |
| SHAREHOLDERS’ CAPITAL DEFICIENCY: | |
| Ordinary shares, par value NIS 0.01 per share; 40,000,000 shares authorized as of December 31, 2023 and 2022; 15,505,853 shares and 15,477,374 shares issued and outstanding at December 31, 2023 and 2022, respectively | |
| Additional paid-in capital | |
| Accumulated deficit | |
| Total redeemable crossover preferred shares and capital deficiency | |
| Total liabilities, net of capital deficiency |
Loading...